Skip to main content
PMC home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 2002 Sep;56(9):707–712. doi: 10.1136/jech.56.9.707

Short-term mortality of myocardial infarction patients with diabetes or hyperglycaemia during admission

J Sala 1, R Masia 1, d Gonzalez 1, J Fernandez-Real 1, M Gil 1, D Bosch 1, W Ricart 1, M Senti 1, J Marrugat 1
PMCID: PMC1732251  PMID: 12177090

Abstract

Aim: The hypothesis that patients with hyperglycaemia during admission, regardless of previous diagnosis of diabetes, have worse prognosis than those with normal glucose values is controversial. The objective was to assess the role of hyperglycaemia on short-term mortality after myocardial infarction (MI).

Methods and Results: A cohort study nested in a prospective registry of MI patients in the reference hospital of Gerona, Spain was performed. All consecutive MI patients under 75 were registered between 1993 and 1996. Patient and clinical characteristics, including previous diagnosis of diabetes, glycaemia on admission and in the next four days, were recorded. Patients with glycaemia on admission or four day mean glycaemia >6.67 mmol/l were considered hyperglycaemic. The main outcome measure was mortality at 28 days. Of 662 patients with MI included, 195 (29.7%) had previously known diabetes mellitus, but 457 (69.0%) had glycaemia >6.67 mmol/l on admission. Patients with hyperglycaemia on admission were older, more often female, more frequently had a previous diagnosis of diabetes, developed more complications, and had higher 28 day mortality. The effect of admission glycaemia >6.67 mmol/l on 28 day mortality was independent of major confounding factors, particularly previous diagnosis of diabetes (OR=4.20, 95% confidence intervals 1.18 to 14.96).

Conclusions: Higher 28 day mortality was observed among MI patients with glycaemia on admission >6.67 mmol/l compared with patients with lower levels, independently of major confounding variables and, particularly, previous diagnosis of diabetes. This early, simple, and inexpensive marker of bad prognosis after MI should prompt the application of more aggressive treatment of MI and risk factors and, probably, of glycaemia during admission.

Full Text

The Full Text of this article is available as a PDF (188.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronson D., Rayfield E. J., Chesebro J. H. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med. 1997 Feb 15;126(4):296–306. doi: 10.7326/0003-4819-126-4-199702150-00006. [DOI] [PubMed] [Google Scholar]
  2. Baumgartner-Parzer S. M., Wagner L., Pettermann M., Gessl A., Waldhäusl W. Modulation by high glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia. 1995 Nov;38(11):1367–1370. doi: 10.1007/BF00401771. [DOI] [PubMed] [Google Scholar]
  3. Bellodi G., Manicardi V., Malavasi V., Veneri L., Bernini G., Bossini P., Distefano S., Magnanini G., Muratori L., Rossi G. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol. 1989 Oct 15;64(14):885–888. doi: 10.1016/0002-9149(89)90836-9. [DOI] [PubMed] [Google Scholar]
  4. Bjørnholt J. V., Erikssen G., Aaser E., Sandvik L., Nitter-Hauge S., Jervell J., Erikssen J., Thaulow E. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. Diabetes Care. 1999 Jan;22(1):45–49. doi: 10.2337/diacare.22.1.45. [DOI] [PubMed] [Google Scholar]
  5. Capes S. E., Hunt D., Malmberg K., Gerstein H. C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000 Mar 4;355(9206):773–778. doi: 10.1016/S0140-6736(99)08415-9. [DOI] [PubMed] [Google Scholar]
  6. Ceriello A. Acute hyperglycaemia and oxidative stress generation. Diabet Med. 1997 Aug;14 (Suppl 3):S45–S49. doi: 10.1002/(sici)1096-9136(199708)14:3+<s45::aid-dia444>3.3.co;2-i. [DOI] [PubMed] [Google Scholar]
  7. Coutinho M., Gerstein H. C., Wang Y., Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999 Feb;22(2):233–240. doi: 10.2337/diacare.22.2.233. [DOI] [PubMed] [Google Scholar]
  8. Díaz R., Paolasso E. A., Piegas L. S., Tajer C. D., Moreno M. G., Corvalán R., Isea J. E., Romero G. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group. Circulation. 1998 Nov 24;98(21):2227–2234. doi: 10.1161/01.cir.98.21.2227. [DOI] [PubMed] [Google Scholar]
  9. Fath-Ordoubadi F., Beatt K. J. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation. 1997 Aug 19;96(4):1152–1156. doi: 10.1161/01.cir.96.4.1152. [DOI] [PubMed] [Google Scholar]
  10. Fuller J. H., Shipley M. J., Rose G., Jarrett R. J., Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br Med J (Clin Res Ed) 1983 Sep 24;287(6396):867–870. doi: 10.1136/bmj.287.6396.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gerstein H. C. Is glucose a continuous risk factor for cardiovascular mortality? Diabetes Care. 1999 May;22(5):659–660. doi: 10.2337/diacare.22.5.659. [DOI] [PubMed] [Google Scholar]
  12. Gerstein H. C., Yusuf S. Dysglycaemia and risk of cardiovascular disease. Lancet. 1996 Apr 6;347(9006):949–950. doi: 10.1016/s0140-6736(96)91420-8. [DOI] [PubMed] [Google Scholar]
  13. Gil M., Marrugat J., Sala J., Masiá R., Elosua R., Albert X., Pena A., Vila J., Pavesi M., Pérez G. Relationship of therapeutic improvements and 28-day case fatality in patients hospitalized with acute myocardial infarction between 1978 and 1993 in the REGICOR study, Gerona, Spain. The REGICOR Investigators. Circulation. 1999 Apr 6;99(13):1767–1773. doi: 10.1161/01.cir.99.13.1767. [DOI] [PubMed] [Google Scholar]
  14. Gilcrease M. Z., Hoover R. L. Examination of monocyte adherence to endothelium under hyperglycemic conditions. Am J Pathol. 1991 Nov;139(5):1089–1097. [PMC free article] [PubMed] [Google Scholar]
  15. Lakhdar A., Stromberg P., McAlpine S. G. Prognostic importance of hyperglycaemia induced by stress after acute myocardial infarction. Br Med J (Clin Res Ed) 1984 Jan 28;288(6413):288–288. doi: 10.1136/bmj.288.6413.288. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lakhdar A. The diagnosis of preexisting diabetes associated with acute myocardial infarction. Diabetes Care. 1998 Mar;21(3):461–461. [PubMed] [Google Scholar]
  17. Lee T. S., Saltsman K. A., Ohashi H., King G. L. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5141–5145. doi: 10.1073/pnas.86.13.5141. [DOI] [PMC free article] [PubMed] [Google Scholar] [Research Misconduct Found]
  18. Mak K. H., Topol E. J. Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus. J Am Coll Cardiol. 2000 Mar 1;35(3):563–568. doi: 10.1016/s0735-1097(99)00628-2. [DOI] [PubMed] [Google Scholar]
  19. Malmberg K., Norhammar A., Wedel H., Rydén L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 1999 May 25;99(20):2626–2632. doi: 10.1161/01.cir.99.20.2626. [DOI] [PubMed] [Google Scholar]
  20. Malmberg K., Rydén L. Myocardial infarction in patients with diabetes mellitus. Eur Heart J. 1988 Mar;9(3):259–264. doi: 10.1093/oxfordjournals.eurheartj.a062494. [DOI] [PubMed] [Google Scholar]
  21. Norhammar A. M., Rydén L., Malmberg K. Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care. 1999 Nov;22(11):1827–1831. doi: 10.2337/diacare.22.11.1827. [DOI] [PubMed] [Google Scholar]
  22. O'Sullivan J. J., Conroy R. M., Robinson K., Hickey N., Mulcahy R. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care. 1991 Aug;14(8):758–760. doi: 10.2337/diacare.14.8.758. [DOI] [PubMed] [Google Scholar]
  23. Oswald G. A., Corcoran S., Yudkin J. S. Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet. 1984 Jun 9;1(8389):1264–1267. doi: 10.1016/s0140-6736(84)92447-4. [DOI] [PubMed] [Google Scholar]
  24. Oswald G. A., Smith C. C., Betteridge D. J., Yudkin J. S. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 1986 Oct 11;293(6552):917–922. doi: 10.1136/bmj.293.6552.917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sala J., Marrugat J., Masiá R., Porta M. Improvement in survival after myocardial infarction between 1978-85 and 1986-88 in the REGICOR study. (Registre GIroní del COR) registry. Eur Heart J. 1995 Jun;16(6):779–784. doi: 10.1093/oxfordjournals.eurheartj.a060996. [DOI] [PubMed] [Google Scholar]
  26. Scheidt-Nave C., Barrett-Connor E., Wingard D. L., Cohn B. A., Edelstein S. L. Sex differences in fasting glycemia as a risk factor for ischemic heart disease death. Am J Epidemiol. 1991 Mar 15;133(6):565–576. doi: 10.1093/oxfordjournals.aje.a115928. [DOI] [PubMed] [Google Scholar]
  27. Sewdarsen M., Vythilingum S., Jialal I., Becker P. J. Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. Q J Med. 1989 May;71(265):461–466. [PubMed] [Google Scholar]
  28. Sodi-Pallares D., Ponce de León J., Bisteni A., Medrano G. A. Potassium, glucose, and insulin in myocardial infarction. Lancet. 1969 Jun 28;1(7609):1315–1316. doi: 10.1016/s0140-6736(69)92251-x. [DOI] [PubMed] [Google Scholar]
  29. Tansey M. J., Opie L. H. Plasma glucose on admission to hospital as a metabolic index of the severity of acute myocardial infarction. Can J Cardiol. 1986 Nov-Dec;2(6):326–331. [PubMed] [Google Scholar]
  30. Vetter N. J., Strange R. C., Adams W., Oliver M. F. Initial metabolic and hormonal response to acute myocardial infarction. Lancet. 1974 Feb 23;1(7852):284–288. doi: 10.1016/s0140-6736(74)92595-1. [DOI] [PubMed] [Google Scholar]
  31. Weissman N. J., Sheris S. J., Chari R., Mendelsohn F. O., Anderson W. D., Breall J. A., Tanguay J. F., Diver D. J. Intravascular ultrasonic analysis of plaque characteristics associated with coronary artery remodeling. Am J Cardiol. 1999 Jul 1;84(1):37–40. doi: 10.1016/s0002-9149(99)00188-5. [DOI] [PubMed] [Google Scholar]
  32. Wilcox R. G. Primary PTCA for acute myocardial infarction--a logistic comment. Eur Heart J. 1996 Mar;17(3):337–338. doi: 10.1093/oxfordjournals.eurheartj.a014864. [DOI] [PubMed] [Google Scholar]
  33. Williams B. Glucose-induced vascular smooth muscle dysfunction: the role of protein kinase C. J Hypertens. 1995 May;13(5):477–486. doi: 10.1097/00004872-199505000-00001. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES